569 related articles for article (PubMed ID: 25808056)
1. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Komori M; Blake A; Greenwood M; Lin YC; Kosa P; Ghazali D; Winokur P; Natrajan M; Wuest SC; Romm E; Panackal AA; Williamson PR; Wu T; Bielekova B
Ann Neurol; 2015 Jul; 78(1):3-20. PubMed ID: 25808056
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation.
Bielekova B; Komori M; Xu Q; Reich DS; Wu T
PLoS One; 2012; 7(11):e48370. PubMed ID: 23226202
[TBL] [Abstract][Full Text] [Related]
3. Molecular-based diagnosis of multiple sclerosis and its progressive stage.
Barbour C; Kosa P; Komori M; Tanigawa M; Masvekar R; Wu T; Johnson K; Douvaras P; Fossati V; Herbst R; Wang Y; Tan K; Greenwood M; Bielekova B
Ann Neurol; 2017 Nov; 82(5):795-812. PubMed ID: 29059494
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases.
Han S; Lin YC; Wu T; Salgado AD; Mexhitaj I; Wuest SC; Romm E; Ohayon J; Goldbach-Mansky R; Vanderver A; Marques A; Toro C; Williamson P; Cortese I; Bielekova B
J Immunol; 2014 Mar; 192(6):2551-63. PubMed ID: 24510966
[TBL] [Abstract][Full Text] [Related]
5. Subclinical central inflammation is risk for RIS and CIS conversion to MS.
Rossi S; Motta C; Studer V; Macchiarulo G; Germani G; Finardi A; Furlan R; Martino G; Centonze D
Mult Scler; 2015 Oct; 21(11):1443-52. PubMed ID: 25583841
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid soluble CD27 is associated with CD8
El Mahdaoui S; Husted SR; Hansen MB; Cobanovic S; Mahler MR; Buhelt S; von Essen MR; Sellebjerg F; Romme Christensen J
J Neuroimmunol; 2023 Aug; 381():578128. PubMed ID: 37321014
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
[TBL] [Abstract][Full Text] [Related]
8. Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis.
Knier B; Leppenetier G; Wetzlmair C; Aly L; Hoshi MM; Pernpeintner V; Biberacher V; Berthele A; Mühlau M; Zimmer C; Hemmer B; Korn T
JAMA Neurol; 2017 Jul; 74(7):847-856. PubMed ID: 28460032
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
[TBL] [Abstract][Full Text] [Related]
10. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.
Takahashi K; Kurihara Y; Suzuki Y; Goshima Y; Tanaka F; Takei K
JAMA Neurol; 2015 Feb; 72(2):176-9. PubMed ID: 25437093
[TBL] [Abstract][Full Text] [Related]
11. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
[TBL] [Abstract][Full Text] [Related]
12. CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage.
Romme Christensen J; Komori M; von Essen MR; Ratzer R; Börnsen L; Bielekova B; Sellebjerg F
Mult Scler; 2019 Jun; 25(7):937-946. PubMed ID: 29775134
[TBL] [Abstract][Full Text] [Related]
13. Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
Talbot J; Højsgaard Chow H; Mahler M; Buhelt S; Holm Hansen R; Lundell H; Vinther-Jensen T; Hellem MNN; Nielsen JE; Siebner HR; von Essen MR; Sellebjerg F
Mult Scler Relat Disord; 2022 Dec; 68():104209. PubMed ID: 36257152
[TBL] [Abstract][Full Text] [Related]
14. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
Orbach R; Gurevich M; Achiron A
Mult Scler; 2014 Jan; 20(1):35-42. PubMed ID: 23722323
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.
Ottervald J; Franzén B; Nilsson K; Andersson LI; Khademi M; Eriksson B; Kjellström S; Marko-Varga G; Végvári A; Harris RA; Laurell T; Miliotis T; Matusevicius D; Salter H; Ferm M; Olsson T
J Proteomics; 2010 Apr; 73(6):1117-32. PubMed ID: 20093204
[TBL] [Abstract][Full Text] [Related]
17. Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
Yuceyar N; Taşkiran D; Sağduyu A
Clin Neurol Neurosurg; 2001 Dec; 103(4):206-11. PubMed ID: 11714562
[TBL] [Abstract][Full Text] [Related]
18. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
[TBL] [Abstract][Full Text] [Related]
19. Features of intrathecal immunoglobulins in patients with multiple sclerosis.
Di Pauli F; Gredler V; Kuenz B; Lutterotti A; Ehling R; Gneiss C; Schocke M; Deisenhammer F; Reindl M; Berger T
J Neurol Sci; 2010 Jan; 288(1-2):147-50. PubMed ID: 19828154
[TBL] [Abstract][Full Text] [Related]
20. Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.
Öhrfelt A; Axelsson M; Malmeström C; Novakova L; Heslegrave A; Blennow K; Lycke J; Zetterberg H
Mult Scler; 2016 Oct; 22(12):1587-1595. PubMed ID: 26754805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
